Artiva Biotherapeutics, Inc. Common Stock ARTV
$4.27
-30.68%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-27 | View → |
| 4 | 4 | 2026-10-07 | View → |
| 4 | 4 | 2026-10-06 | View → |
| 4 | 4 | 2026-10-06 | View → |
| 4 | 4 | 2026-10-06 | View → |
| 4 | 4 | 2026-10-06 | View → |
| 4 | 4 | 2026-09-15 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | Insider transaction | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-11 | View → |
| 4 | 4 | 2026-09-11 | View → |
| 4 | 4 | 2026-09-11 | View → |
| 4 | 4 | 2026-09-11 | View → |
| 8-K | 8-K | 2026-09-11 | View → |
| 4 | 4 | 2026-09-09 | View → |
| 4 | Insider transaction | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 4 | 4 | 2026-09-04 | View → |
| 4 | 4 | 2026-09-04 | View → |
| 4 | 4 | 2026-09-04 | View → |
| 4 | 4 | 2026-09-04 | View → |
| 4 | 4 | 2026-08-31 | View → |
| 4 | 4 | 2026-08-19 | View → |
| S-3 | S-3 | 2026-08-06 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| DEF 14A | DEF 14A | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-07-31 | View → |
| 4 | Insider transaction | 2026-07-28 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $4.27
- Market Cap
- $301.16 million
- 52-Week Range
- $2.52 – $14.53
- Average Volume
- 794K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.